Underserved Patient Populations With Metastatic Breast Cancer: A Review of Progress and Remaining Challenges [0.03%]
转移性乳腺癌不足人群患者:进展和剩余挑战综述
Fatima Cardoso,Rachel Wuerstlein,Tomoyuki Aruga et al.
Fatima Cardoso et al.
Breast cancer presents a significant risk to public health and is the primary cause of cancer-related death in women. Awareness of metastatic breast cancer (mBC) continues to increase, and advances have been made; however, challenges remain...
Clinical Outcomes of CDK4/6 Inhibitor Therapy in HR+/HER2- Metastatic Breast Cancer: A Multicenter Comparison of HER2-Low and HER2-Zero Subgroups [0.03%]
CDK4/6抑制剂治疗HR+/HER2-转移性乳腺癌的临床结局:HER2低表达与无HER2组的多中心比较分析
Erkan Ozcan,Ivo Gokmen,Fahri Akgul et al.
Erkan Ozcan et al.
Background: The clinical impact of HER2-low status on the efficacy of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i). Therapy in patients with hormone receptor-positive (HR+), HER2-negative metastatic breast cancer (MBC) remains unclear. M...
Comparative Study
The breast journal. 2025 Jun 27:2025:5577345. DOI:10.1155/tbj/5577345 2025
Extratumoral Signs of Malignant Nonspiculate and Noncalcified Masses on Mammography: Are They Associated With Prognostic Factors in Breast Cancer? [0.03%]
乳腺恶性无刺状和非钙化肿块的瘤周征象:它们与乳腺癌预后因素有关吗?
Ye Xu,Xinxin Yang,Fei Wang et al.
Ye Xu et al.
Aim: To investigate the association between mammographic extratumoral signs, specifically their subclassifications, of nonspiculate and noncalcified masses (NSNCMs) and prognostic factors in breast cancer. Materials and Methods: This retros...
Efficacy of Presurgical Short-Term Endocrine Therapy During the Waiting Period for Surgery in Postmenopausal Hormone Receptor-Positive Breast Cancer [0.03%]
围手术期短期内分泌治疗绝经后激素受体阳性乳腺癌患者的疗效研究
Yuka Maeda,Ayana Sato,Akiko Matsumoto et al.
Yuka Maeda et al.
Background: Although presurgical endocrine therapy has been used to enhance the rate of breast cancer conservation, its prognostic relevance is unknown. The search for a valid prognostic factor equivalent to pathological complete response i...
Exploring New Frontiers: Alternative Breast Cancer Treatments Through Glycocalyx Research [0.03%]
探索新前沿:通过糖萼研究探讨乳腺癌的替代治疗方法
Ielizaveta Gorodetska,Anastasiia Samusieva,Tetiana Lahuta et al.
Ielizaveta Gorodetska et al.
Breast cancer (BC) treatment is developing toward more precise and personalized care through the approval of different comprehensive approaches. Clinical practice emphasizes significant patient-to-patient variability in treatment response a...
Pretreatment Axillary Nodal Volume as a Prognostic Factor for Breast Cancer [0.03%]
术前腋窝淋巴结体积是乳腺癌预后因素
Yuri Jeong,Jung Hoon Kim,Su Ssan Kim et al.
Yuri Jeong et al.
Background and Objectives: We evaluated the prognostic value of pretreatment axillary nodal volume in breast cancer patients treated with neoadjuvant systemic therapy. Methods: We retrospectively reviewed 302 breast cancer patients with bio...
Development of a Prognostic Score in Patients With Advanced Breast Cancer Treated for Meningeal Carcinomatosis [0.03%]
开发预测接受治疗脑膜癌病的晚期乳腺癌患者的预后评分
Grégoire Narjoux,Juliette Mainguené,Marie-Noëlle Guilhaume et al.
Grégoire Narjoux et al.
Purpose: Meningeal carcinomatosis (MC) has a dismal prognosis in patients with breast cancer and requires invasive therapies. The aim of the present retrospective study was to determine a prognostic score for overall survival (OS) in patien...
Identification of the Molecular Subtype and Prognostic Characteristics of Breast Cancer Based on Tumor-Infiltrating Regulatory T Cells [0.03%]
基于肿瘤浸润调节性T细胞的乳腺癌分子分型及预后特征识别
Jianying Ma,Gang Hu,Lianghong Kuang et al.
Jianying Ma et al.
Background: T regulatory cells (Tregs) are essential for preserving immune tolerance. They are present in large numbers in many tumors, hindering potentially beneficial antitumor responses. However, their predictive significance for breast ...
Mehmet Furkan Sağdıç,Cihangir Özaslan
Mehmet Furkan Sağdıç
Background: Breast carcinoma is divided into at least 21 separate histologies, according to the 2019 World Health Organization (WHO) classification. The present study is dedicated to a 5% or rarer group of all breast cancer cases. Method: I...
Florid Lobular Carcinoma In Situ: Imaging Characteristics and Pathologic Upgrade Rates on Surgical Excision [0.03%]
原位小叶癌的影像学特征及手术切除病理升级率分析
Anshumi Desai,Susan B Kesmodel,Barbara Susnik et al.
Anshumi Desai et al.
Background: Florid lobular carcinoma in situ is an uncommon lobular neoplasia variant that is frequently associated with invasive carcinoma. However, there remains a paucity of information to guide management. The authors aimed to study ima...